secwatch.observer — SEC 8-K summary
======================================

Issuer:     Cardiff Oncology, Inc. (CRDF)
CIK:        0001213037
Form:       8-K
Filed at:   2023-07-24T23:59:59+00:00
Accession:  0001628280-23-025483
Event type: other
Sentiment:  neutral
Materiality: 0.20
Item codes: 8.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Cardiff Oncology grants 50,016 stock options to new employee as inducement
--------------------------------------------------------------------------

- Grant of non-qualified stock options for 50,016 shares at $1.49 per share.
- Options vest over 4 years: 25% after 1 year, then monthly for 36 months.
- Grant made as inducement material to new employee's hiring under Nasdaq Rule 5635(c)(4).
- One new employee received the award on July 24, 2023.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1213037/000162828023025483/0001628280-23-025483-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1213037/000162828023025483/crdf-20230724.htm
  HTML page:      https://secwatch.observer/filing/0001628280-23-025483

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer